Evaluation of the efficacy and safety of imipenem/cilastatin in the treatment of complicated urinary tract infections.
Goldoni
S
S
Chair of Urology, Department of Surgery, L'Aquila University Medical School, L'Aquila, Italy.
Gandolfi
P
P
Tubaro
A
A
Vicentini
C
C
Lancione
P
P
Miano
L
L
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015377:Cilastatin / Q000627:therapeutic use; D000077728:Cilastatin, Imipenem Drug Combination; D004338:Drug Combinations; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D012449:Safety; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000209:etiology; D014570:Urologic Diseases / Q000150:complications
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D004791:Enzyme Inhibitors; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination